Treatment of High Risk DLBCL with DA-R-EPOCH in Those Unable to Tolerate Intensive Chemotherapy: Well-Tolerated and Effective, but Inadequate in Double/Triple Hit or Expressing DLB... by Leslie, Lori A., Kothadia, Sejal, Protomastro, Ewelina, Greenberg, Patricia J, Andrews, Tracy, McNeill, Ann, Iida, Hoshiyuki, Skarbnik, Alan P, Yang, Xiao, Bhattacharyya, Pritish K., Chow, Kar Fai, Goldberg, Stuart L., Pecora, Andrew L., Feldman, Tatyana A, Goy, Andre

Get full text